• BIVDA members area

Members' Press Releases

From the monthly archives: July, 2013

We are pleased to present below all posts archived in 'July, 2013'. If you still can't find what you are looking for, try using the search box.

Siemens expands haematology portfolio with CellaVision distribution agreement

A distribution agreement between Siemens Healthcare Diagnostics and CellaVision has recently commenced. The strategic collaboration is enabling Siemens to complement its existing portfolio of haematology solutions with CellaVision’s digital microscopy haematology products.

Read the rest of entry »

New Data Shows CK1d Blocks Tau in AD Model

Proteome Sciences yesterday made two poster presentations showing new data and results from its novel casein kinase 1 delta (CK1d) inhibitor program in Alzheimer's disease. The results show that the two lead compounds are orally available, attain therapeutic levels in the brain of experimental Alzheimer's models and improve cognitive behaviour. When the tau protein of treated animals was analysed a decrease was seen at key sites in total tau deposition and in tau phosphorylation.

Read the rest of entry »

Diagnosis and monitoring of cancer patients made easier with three new automated assays

Roche launches thyroid and lung cancer marker assays for easy consolidation on to automated platforms

Three automated assays, that will allow laboratories to provide clinicians with information to aid the diagnosis and monitoring of cancer patients, have been added to the extensive Roche assay menu. 

Read the rest of entry »

Atomo Diagnostics and BBI Solutions announce an agreement to commercialise next generation rapid test platform worldwide

 BBI

Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo’s award winning, integrated rapid blood test platform, AtomoRapid™. 

AtomoRapid™ is a convenient, hand-held rapid blood test device that simplifies procedures, eliminating the need for complex test kits containing multiple items. 

Read the rest of entry »

Orla Proteins boosted by Roger Duggan appointment

Medical diagnostic technology specialist Dr Roger Duggan, formerly of Immunodiagnostic  Systems plc (IDS), has joined the board of the life sciences company Orla Protein Technologies Ltd.

Read the rest of entry »

Diagnosis of Parvovirus B19 enhanced with launch of unique highly sensitive molecular assay

The molecular division of DiaSorin has launched the unique, highly sensitive Iam Parvo assay, a rapid quantitative molecular assay for use on the Liaison® Iam instrument. DiaSorin are the global leader in Parvovirus B19 serology testing, and the addition of this molecular assay expands its diagnostic portfolio for this potentially life-threatening virus.

Read the rest of entry »

Archive